Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

Kaplan-Meier analysis showed a statistically significant difference in overall survival favoring immediate treatment (log-rank p = 0.002), though recurrence-free survival did not differ significantly ...

Valentina Milanova believed she 'was dying' when she experienced her first period aged nine, but has since set up a business ...

Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

Ms Milanova, now 30, got her first period at just nine but, without any education about menstruation, feared she was gravely ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic ...

Despite the diagnosis, Valentina continued to grapple with cysts, severe pain, bloating, and heavy bleeding. Her personal ...

Valentina Milanova, 30, had her first period at nine years old and put on the pill at 11 after experiencing excruciating pain ...

Emma Weston joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

Dr. Hyung L. Kim discusses how the addition of cytoreductive nephrectomy to ICI therapy may affect survival and quality of ...

A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage ...